Brigitte Evrard - Search Results

Year	Number of Results
2002	1
2004	4
2005	4
2006	5
2007	6
2008	6
2010	5
2011	5
2012	1
2013	2
2014	2
2015	9
2016	11
2017	9
2018	3
2019	6
2020	8
2021	4

1

Lipid gene nanocarriers for the treatment of skin diseases: Current state-of-the-art.

Bellefroid C, Lechanteur A, Evrard B, Piel G. Bellefroid C, et al. Among authors: evrard b. Eur J Pharm Biopharm. 2019 Apr;137:95-111. doi: 10.1016/j.ejpb.2019.02.012. Epub 2019 Feb 19. Eur J Pharm Biopharm. 2019. PMID: 30794856 Review.

2

Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: A review.

Jennotte O, Koch N, Lechanteur A, Evrard B. Jennotte O, et al. Among authors: evrard b. Int J Pharm. 2020 Apr 30;580:119200. doi: 10.1016/j.ijpharm.2020.119200. Epub 2020 Mar 8. Int J Pharm. 2020. PMID: 32156531 Review.

3

Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review.

Lechanteur A, Evrard B. Lechanteur A, et al. Among authors: evrard b. Pharmaceutics. 2020 Jan 9;12(1):55. doi: 10.3390/pharmaceutics12010055. Pharmaceutics. 2020. PMID: 31936628 Free PMC article. Review.

4

Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review.

Nyamba I, Lechanteur A, Semdé R, Evrard B. Nyamba I, et al. Among authors: evrard b. Eur J Pharm Biopharm. 2021 Feb;159:198-210. doi: 10.1016/j.ejpb.2020.11.004. Epub 2020 Nov 14. Eur J Pharm Biopharm. 2021. PMID: 33197529

5

A supercritical fluid technology for liposome production and comparison with the film hydration method.

Penoy N, Grignard B, Evrard B, Piel G. Penoy N, et al. Among authors: evrard b. Int J Pharm. 2021 Jan 5;592:120093. doi: 10.1016/j.ijpharm.2020.120093. Epub 2020 Nov 16. Int J Pharm. 2021. PMID: 33212171

6

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.

Karim R, Palazzo C, Evrard B, Piel G. Karim R, et al. Among authors: evrard b. J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16. J Control Release. 2016. PMID: 26892752 Review.

7

Chromametric assessment of drug skin tolerance: A comparative study between Africans and Caucasians skins.

Sounouvou HT, Lechanteur A, Quetin-Leclercq J, Piel G, Donneau AF, Gbaguidi F, Evrard B. Sounouvou HT, et al. Among authors: evrard b. Skin Res Technol. 2020 May;26(3):329-337. doi: 10.1111/srt.12804. Epub 2019 Nov 29. Skin Res Technol. 2020. PMID: 31785045

8

Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers.

Koch N, Jennotte O, Gasparrini Y, Vandenbroucke F, Lechanteur A, Evrard B. Koch N, et al. Among authors: evrard b. Int J Pharm. 2020 Nov 15;589:119812. doi: 10.1016/j.ijpharm.2020.119812. Epub 2020 Aug 31. Int J Pharm. 2020. PMID: 32882367

9

Ozone-primed neutrophils promote early steps of tumour cell metastasis to lungs by enhancing their NET production.

Rocks N, Vanwinge C, Radermecker C, Blacher S, Gilles C, Marée R, Gillard A, Evrard B, Pequeux C, Marichal T, Noel A, Cataldo D. Rocks N, et al. Among authors: evrard b. Thorax. 2019 Aug;74(8):768-779. doi: 10.1136/thoraxjnl-2018-211990. Epub 2019 May 29. Thorax. 2019. PMID: 31142617

10

Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled?

Lechanteur A, Evrard B, Piel G. Lechanteur A, et al. Among authors: evrard b. Eur J Pharm Biopharm. 2019 Nov;144:2-10. doi: 10.1016/j.ejpb.2019.09.001. Epub 2019 Sep 4. Eur J Pharm Biopharm. 2019. PMID: 31493512 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results